Novel PIK3CD mutations affecting N-terminal residues of p110d cause activated PI3Kd syndrome (APDS) in humans

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

MOSBY-ELSEVIER

1. National Institute of Allergy and Infectious Diseases/National Institutes of Health
2. Yale University from the National Heart, Lung, and Blood Institute [R00HL125668]
3. CIHR
4. Natural Sciences and Engineering Research Council of Canada [NSERC-2014-05218]
5. Department of Laboratory Medicine at the Clinical Center, National Institutes of Health.